COPD-Management NICE - COPD Treatment Nice - A4medicine

50 %
50 %
Information about COPD-Management NICE - COPD Treatment Nice - A4medicine

Published on December 10, 2019

Author: a4medicineuk


Slide 1: COPD-Management NICE - COPD Treatment Nice - A4medicine WWW.A4MEDICINE.CO.UK Slide 2: WWW.A4MEDICINE.CO.UK Chronic obstructive pulmonary disease- a summary of NICE draft July 2018. Smoking cessation- Take and document hx of smoking
○ pack yrs smoked 
 ie No of cigs / D divided by 20 and multiplied by number of yrs smoked
 Advice to stop smoking at every opportunity – regardless of age and offer help to do so
 Consider issuing – unless contraindicated
○ nicotine replacement therapy
○ vareniciline or
○ bupropion 
appropriate support Programme for Behavioral support Visit: COPD Treatment Nice Slide 3: WWW.A4MEDICINE.CO.UK Inhaled therapy –Short acting beta2 agonists ( SABA ) and Short acting muscarinic antagonists ( SAMA ) as necessary as the initial treatment to relieve breathlessness and exercise limitation – as necessary . NICE advices against using a response to oral corticosteroid 
( oral corticosteroid reversibility tests ) to selaect patients for initiation of inhaled steroid therapy
 Be ready to discuss the risk of side effects 
( including pneumonia ) in people who take inhaled corticosteroids
( ICS ) for COPD ) Inhaled combination therapy- This refers to combinations of LAMA , LABA and ICS ie 
Long acting preparations as opposed to Short acting when initiating treatment
 LAMA is long acting muscarinic antagonists as
glycopyrronium , umeclidinium , aclidinium
 LABA is long acting beta2 agonists as
Indacaterol , formoterol , striverdi Talk to Us: Talk to Us EMAIL ADDRESS WWW.A4MEDICINE.CO.UK

Add a comment

Related presentations